Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CEUS with Definity/Lumason for Kidney Cancer Screening in VHL
NCT03907657Phase 2Completed
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Start
- Sep 2019
- Primary completion
- Mar 2023
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of perflutren lipid microspheres, sulfur hexafluoride in kidney cancer, sponsored by UNC Lineberger Comprehensive Cancer Center. Started Sep 2019; status: completed.
02
Drugs
perflutren lipid microspheressulfur hexafluoride
03
Conditions
kidney cancer
Beyond the preview
Go deeper on NCT03907657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03907657.